Preterm Birth Prevention and Management Market
Market Insights on Preterm Birth Prevention and Management covering sales outlook, demand forecast & up-to-date key trends
Preterm Birth Prevention and Management Market by Therapy Type (Progesterone Therapy, Corticosteroid Therapy, Tocolytics Therapy, Antihypertensive Therapy, Magnesium Sulfate Therapy, Heparin Prophylaxis Therapy, Low-Dose Aspirin Therapy, Antibiotics Therapy) & Region for 2022-2029
Preterm Birth Prevention and Management Market Outlook – 2022-2029
[302 Pages Report] The global Preterm Birth Prevention and Management Market is estimated to be worth around US$ 1.41 Bn in 2022. With increasing adoption of preterm birth prevention and management therapeutics across both developed and developing regions, the overall market is anticipated to grow at 10.1% CAGR between 2022 and 2029, totaling a valuation of US$ 2 .78 Bn by 2029.
|
Attribute |
Details |
|
Preterm Birth Prevention and Management Market Estimated Size in 2022 |
US$ 1.41 Bn |
|
Preterm Birth Prevention and Management Market Projected Size in 2029 |
US$ 2.78 Bn |
|
Preterm Birth Prevention and Management Market Historical CAGR (2014-2021) |
7.9% |
|
Preterm Birth Prevention and Management Market Value-Based CAGR (2022-2029) |
10.1% |
Preterm birth has become a major healthcare problem and a significant contributor to perinatal mortality and disability worldwide. In order to address this issue, various approaches are being employed by healthcare workers. This is in turn providing impetus to the preterm birth prevention and management market and the trend is likely to continue in the future. Currently preterm birth prevention and management represents 12.4% of the global prenatal care market.
Regionally, North America and South Asia remain the two most attractive markets for preterm birth prevention and management therapeutic, owing to the rising prevalence of preterm birth, presence of leading market players, new drug development and approvals and increasing government support.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
9.67% |
|
H1, 2022 Projected |
10.08% |
|
H1, 2022 Outlook |
8.98% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 110 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 69 ↓ |
H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 110 BPS. In H1-2022, the market growth rate of preterm birth prevention and management is expected to fall by 69 basis point share (BPS), as per FMI analysis.
The key developments in the market include the specified WHO guidelines in the management of preterm birth and management of overall maternal health. The market is highly influenced by biologic manufacturing impositions, regulatory framework, and licensing of therapeutic agents.
The market decline observed through the drop in the BPS values is addressed by the advent of the COVID-19 pandemic and the resultant halt in the production capacities as well as supply chain disruptions. This notable change reduced the proliferation of preterm birth prevention therapeutics.
Consequently, the development of several government initiatives to improve maternal and child health will support the market growth, and will likely result in the advancement in growth of the overall preterm birth prevention and management market.
2014-2021 Preterm Birth Prevention and Management Market Outlook Compared to 2021-2029 Forecast
As per FMI, the global preterm birth prevention and management market is set to register a steady CAGR of 10.1% between 2022 and 2029 in comparison to 7.9% CAGR registered from 2014 to 2021.
Rising need for preventing preterm births, growing health awareness among people and increasing emphasis on targeted therapies are some of the factors driving the global preterm birth prevention and management market.
The increasing prevalence of preterm births at an alarming rate has become one of the major concerns for healthcare workers and governing bodies worldwide. It not only puts life of both baby and mother in danger but also incurs heavy financial losses.
According to the World Health Organization (WHO), an estimated 15 million babies are born preterm every year and around 1 million children die each year due to complications of preterm birth. This rise in preterm births worldwide is providing the major thrust to the growth of preterm birth prevention and management market and the trend is likely to continue in the future.
Consequently, increasing adoption of preterm diagnostic tests for better assessment is positively impacting the growth of preterm birth prevention and management market.
Leading market players are vigorously spending on research activities for developing novel treatment approaches. New combination therapies are being studied for the proper management of preterm birth and post preterm birth complications worldwide.
For instance, in 2021, researchers at the University of Texas Medical Branch (UTMB) developed a new treatment approach that could reduce the incidence of preterm birth, while treating the fetus as the patient.
Besides this, they are aiming at penetrating the lucrative market of developing regions to increase their sales.
Spurred by aforementioned factors, the preterm birth prevention and management market is set to expand 1.96X through 2029.
What are the Factors Driving Preterm Birth Prevention and Management Market?
“Growing Concerns Regarding High Mortality Rate of Preterm Birth Triggering Growth”
Preterm birth is defined as the delivery of a fetus before 37 weeks of pregnancy. Early child birth can lead to various complications including long term disability and death of the child. It is one of the leading causes of neonatal death. According to the World Health Organization (WHO), Preterm birth complications were the leading cause of death among children under 5 years of age in 2015.
Rising concerns regarding the long-term disability and mortality rate of preterm birth are impelling the adoption of various treatment approaches like progesterone and corticosteroid therapies. Growing popularity of these treatment approaches among people will continue to spur the growth of preterm birth prevention and management market over the assessment period.
“Increasing Initiatives Taken by Government and Private Organizations Pushing Sales”
Amid rising mortality rate associated with preterm births, improving prenatal health has become a top priority for both protecting the child as well as the mother. Various initiatives have been adopted by government and private organizations from time to time to develop proper prenatal care infrastructure. This has created huge space for the leading market players.
Moreover, various investments are being allocated to healthcare institutions for reducing preterm birth and improving prenatal care across the world.
For instance, in 2021, the National Consumer League (NCL) along with patient advocacy organizations launched Preterm Birth Prevention Alliance (PBPA) to reduce recurrent preterm birth cases.
Similarly in September 2021, the U.S. Department of Health and Human Services (HHS) awarded nearly US$ 350 million in awards to states across the nation to support safe pregnancies and healthy babies
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-wise Insights
Why is the Preterm Birth Prevention and Management Market Flourishing in India?
“Rising Incidence of Preterm Birth Augmenting Market Growth”
During the last few years India has emerged as a highly lucrative market for preterm birth prevention and management therapeutics across South Asia. The market in the country is driven by rapidly increasing population, rising governmental support, increasing prevalence of preterm birth and growing health awareness among people.
Rising cases of preterm births and high infant mortality rate are creating high demand for preterm birth prevention and management therapeutics across the country. According to the World Health organization (WHO), India remains the biggest contributor to the global burden of preterm births, accounting for over 3,519 100 cases.
Various initiatives and campaigns are being launched by both government and private organizations to tackle the rising burden of preterm births. This will further support the growth of term birth prevention and management market in the country over the assessment period.
What is the Market Outlook for China?
“Increase in Spontaneous Preterm Births Pushing Sales in China”
As per FMI, the China preterm birth prevention and management market is anticipated to grow at a stupendous CAGR over the forecast period. Increasing cases of spontaneous preterm births, easy availability of multiple therapeutics at affordable rates and favorable government regulations are some of the major factors driving the preterm birth prevention and management market in China.
During the last few years, China has witnessed a sharp increase in the cases of preterm births. The country has become the second biggest contributor to the global burden of preterm births with over 1 172 300 cases as per WHO. This rise in preterm birth cases has put preterm birth prevention and management market into the spotlight.
Moreover, the presence of favorable regulations and increasing investments by government on developing the country’s neonatal care infrastructure is positively impacting market growth and the trend is likely to continue in the future.
Why is the U.S. Considered a Leading Market for Preterm Birth Prevention and management?
“Presence of Leading Market Players and Favorable Reimbursement Policies Triggering Growth in U.S.”
The U.S. has become one of the most lucrative markets for preterm birth prevention and management due to heavy presence of leading market players, highly established healthcare sector, rising diagnostic rates, availability of favorable reimbursement policies and growing awareness among people regarding pregnancy and infant loss.
Changing lifestyle along with increasing adoption of assistant reproductive technologies in the country has resulted in more multiple pregnancies with high complications. This has pushed the number of preterm births to new heights.
However, with continuous advances in prenatal care and rising government support, the country is gradually becoming successful in countering this rising issue of preterm birth. Huge amounts are being constantly spent on diagnostic tests and preterm birth management treatments.
Moreover, the country is home to some of the leading pharmaceutical giants who are increasingly developing innovative drugs for addressing the preterm birth issue.
Category-wise Insights
Which is the Most Commonly Used Therapy Type for Preterm Birth Prevention and Management?
“Progesterone Therapy Remains Highly Sought After for Preventing Preterm Birth”
As per FMI, progesterone therapy will continue to remain the most preferred treatment for preventing preterm births owing to its fast action and better efficacy. It is highly recommended by healthcare professionals as it doesn’t require surgery or anesthesia.
Progesterone helps to prevent preterm birth in patients with short cervix, prior spontaneous PTB and several other complications.
Increasing adoption of progesterone therapy for preterm birth prevention and management is anticipated to accelerate the growth of the market at a prolific pace during the forecast period.
Which is the Most Preferred Route of Administration for Preterm Birth Prevention and Management Therapeutics?
“Faster and Higher Bioavailability of Parenteral Route of Administration Making it a Preferred Choice”
Based on route of administration, the global preterm birth prevention and management market is categorized into oral, parenteral and vaginal. Among these, parenteral segment is anticipated to continue its dominance in the global preterm birth prevention and management market, accounting for a major share of 79.3 in 2022.
Healthcare workers mostly administer preterm birth prevention and management therapeutics such as progesterone and corticosteroid through parenteral route due to its various advantages. The parenteral route of administration offers improved bioavailability, reliable dosing and avoidance of the first pass metabolism.
Which Distribution Channel Will Witness Maximum Sales of Preterm Birth Prevention and Management Drugs?
“Hospital Pharmacies Remain the Most Preferred Distribution Channel for Preterm Birth Prevention and Management Therapeutics”
In terms of distribution channel, preterm birth prevention and management market has been segmented into hospital pharmacies, retail pharmacies, drug stores and mail order pharmacies. Among these, the hospital pharmacies segment accounts for the largest revenue share and is projected to continue its dominance during the forecast period.
Most of the patients prefer to opt for treatment at government hospitals in order to minimize the overall costs. As a result, hospital pharmacies witness more demand for preterm birth prevention and management therapeutics and the trend is likely to continue in the future.
Moreover, shareholders continue to allocate their capitals to hospital pharmacies for distribution of preterm birth prevention and management drugs.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Competitive Landscape
Leading companies operating in the global preterm birth prevention and management market have adopted various organic and inorganic strategies such as mergers, partnerships, new product launches and approvals, collaborations and acquisitions for expanding their global presence. For instance,
- In August 2021, the U.S. Food and Drug Administration granted a public hearing to discuss Makena, the only FDA approved treatment for reducing preterm birth in indicated patients, as per Covis Group.
- In 2020, Covis Group acquired AMAG Pharmaceuticals to become a global market leader of therapeutic solutions for various life-threatening conditions and chronic illness.
- In July 2019, Novartis AG announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended its approval of Lucentis for the treatment of preterm infants with retinopathy of prematurity.
Scope of the Report
|
Attribute |
Details |
|
Historical Data Available for |
2014-2021 |
|
Forecast Period |
2022-2029 |
|
Market Analysis |
Units for Volume and US$ Mn for Value |
|
Key Regions Covered |
North America, Europe, Latin America, South Asia, East Asia, Oceania and Middle East and Africa |
|
Key Countries Covered |
US, Canada, Mexico, Brazil, Germany, U.K., France, Italy, Spain, Russia, Poland, China, Japan, South Korea, India, ASEAN, Turkey and South Africa |
|
Key Segments Covered |
Therapy Type, Route of Administration, Patient Type, Distribution Channel, and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Preterm Birth Prevention and Management Market by Category
By Therapy Type:
- Progesterone Therapy
- Corticosteroid Therapy
- Tocolytics Therapy
- Antihypertensive Therapy
- Magnesium Sulfate Therapy
- Heparin Prophylaxis Therapy
- Low-Dose Aspirin Therapy
- Antibiotics Therapy
By Route of Administration:
- Oral
- Parenteral
- Vaginal
By Patient Type:
- Prior Spontaneous PTB
- Preeclampsia
- Short Cervix
- Chronic Hypertension
- Insulin-dependent
- Twins
- Antiphospholipid Antibody Syndrome
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Mail Order Pharmacies
By Region:
- North America
- Europe
- Latin America
- South Asia
- East Asia
- Oceania
- Middle East and Africa
Frequently Asked Questions
The preterm birth prevention and management market is estimated to be worth around US$ 1.41Bn in 2022.
As per FMI, the preterm birth prevention and management market is forecast to register a CAGR of 10.1% between 2022 and 2029
The preterm birth prevention and management market grew at a CAGR of 7.9% between 2014 and 2021.
Introduction of new therapeutics, rising government support and surging cases of preterm births are some of the key trends shaping the growth of the market.
Aquatic Remedies Pvt. Ltd., Teva Pharmaceuticals USA, Inc., Anglo French Drugs & Industries Limited, Biophar Lifesciences Pvt. Ltd., Jasco Labs (P) Ltd., BSA Pharma Inc., Novartis AG, Sanofi S.A, AMAG Pharmaceuticals, Pfizer Inc., and Mylan are some of the leading players operating in the preterm birth prevention and management market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP Growth Outlook
4.1.2. Global Healthcare Expenditure Outlook
4.2. Forecast Factors - Relevance & Impact
4.2.1. Incidences of Preterm Birth
4.2.2. Treatment Cost
4.2.3. Availability of Reimbursement
4.2.4. Awareness Regarding Preterm Birth Prevention
4.2.5. Expected Drug Launches
4.3. Value Chain Analysis
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.5. Opportunity Analysis
5. Key Success Factors
5.1. Epidemiology of Preterm Birth for Top Countries
5.2. Treatment Regime by Patient Type
5.3. Research and Development Strategies by Key Vendors
5.4. Regulatory Scenario
5.5. Exhaustive List of FDA and EMA approved Drugs
5.6. Pipeline Assessment
5.7. Reimbursement Landscape for Top Countries
5.8. Patent Scenario
5.9. Emerging drug delivery platform for PTB prevention & management
5.10. Key Marketed Drug - Historic Sales Analysis and Forecast
5.11. License Deal Summary for Key Marketed Drugs
5.12. Medical Need Assessment / Gap Analysis
6. Global Preterm Birth Prevention and Management Market Pricing Analysis
6.1. Regional Pricing Analysis By Therapy Type
6.2. Global Average Pricing Analysis Benchmark
7. Global Preterm Birth Prevention and Management Market Value (US$ Mn) Analysis 2014-2021 and Forecast, 2022-2029
7.1. Historical Market Value (US$ Mn) Analysis, 2014-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029, by Therapy Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Therapy Type, 2014-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Therapy Type, 2022-2029
8.3.1. Progesterone Therapy
8.3.2. Corticosteroid Therapy
8.3.3. Tocolytics Therapy
8.3.4. Antihypertensive Therapy
8.3.5. Magnesium Sulfate Therapy
8.3.6. Heparin Prophylaxis Therapy
8.3.7. Low-Dose Aspirin Therapy
8.3.8. Antibiotics Therapy
8.4. Market Attractiveness Analysis By Therapy Type
9. Global Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029, by Route of Administration
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2014-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2022-2029
9.3.1. Oral
9.3.2. Parenteral
9.3.3. Vaginal
9.4. Market Attractiveness Analysis By Route of Administration
10. Global Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029, by Patient Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2014-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Patient Type, 2022-2029
10.3.1. Prior Spontaneous PTB
10.3.2. Preeclampsia
10.3.3. Short Cervix
10.3.4. Chronic Hypertension
10.3.5. Insulin-dependent
10.3.6. Twins
10.3.7. Antiphospholipid Antibody Syndrome
10.3.8. Others
10.4. Market Attractiveness Analysis By Patient Type
11. Global Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029, By Distribution Channel
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2029
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Drug Stores
11.3.4. Mail Order Pharmacies
11.4. Market Attractiveness Analysis By Distribution Channel
12. Global Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2021
12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2029
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 - 2028
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Therapy Type
13.3.3. By Route of Administration
13.3.4. By Patient Type
13.3.5. By Distribution Channel
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Latin America Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 - 2028
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Therapy Type
14.3.3. By Route of Administration
14.3.4. By Patient Type
14.3.5. By Distribution Channel
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Europe Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 - 2028
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Poland
15.3.1.9. Rest of Europe
15.3.2. By Therapy Type
15.3.3. By Route of Administration
15.3.4. By Patient Type
15.3.5. By Distribution Channel
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. South Asia Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 - 2028
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Singapore
16.3.1.4. Indonesia
16.3.1.5. Malaysia
16.3.1.6. Rest of South Asia
16.3.2. By Therapy Type
16.3.3. By Route of Administration
16.3.4. By Patient Type
16.3.5. By Distribution Channel
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. East Asia Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 - 2028
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Therapy Type
17.3.3. By Route of Administration
17.3.4. By Patient Type
17.3.5. By Distribution Channel
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Oceania Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 - 2028
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Therapy Type
18.3.3. By Route of Administration
18.3.4. By Patient Type
18.3.5. By Distribution Channel
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 - 2028
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkey
19.3.1.3. South Africa
19.3.1.4. Rest of Middle East and Africa
19.3.2. By Therapy Type
19.3.3. By Route of Administration
19.3.4. By Patient Type
19.3.5. By Distribution Channel
19.4. Market Attractiveness Analysis
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Emerging Countries Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029
20.1. Introduction
20.1.1. Market Value Proportion Analysis, By Key Countries
20.1.2. Global Vs. Country Growth Comparison
20.2. China Preterm Birth Prevention and Management Market Analysis
20.2.1. Introduction
20.2.2. Market Value Proportion Analysis by Market Taxonomy
20.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.2.3.1. By Therapy Type
20.2.3.2. By Route of Administration
20.2.3.3. By Patient Type
20.2.3.4. By Distribution Channel
20.3. India Preterm Birth Prevention and Management Market Analysis
20.3.1. Introduction
20.3.2. Market Value Proportion Analysis by Market Taxonomy
20.3.3. Market and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.3.3.1. By Therapy Type
20.3.3.2. By Route of Administration
20.3.3.3. By Patient Type
20.3.3.4. By Distribution Channel
20.4. Brazil Preterm Birth Prevention and Management Market Analysis
20.4.1. Introduction
20.4.2. Market Value Proportion Analysis by Market Taxonomy
20.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.4.3.1. By Therapy Type
20.4.3.2. By Route of Administration
20.4.3.3. By Patient Type
20.4.3.4. By Distribution Channel
21. U.S. Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029
21.1. Introduction
21.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
21.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
21.3.1. By Therapy Type
21.3.2. By Route of Administration
21.3.3. By Patient Type
21.3.4. By Distribution Channel
21.4. Market Attractiveness Analysis
22. Canada Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029
22.1. Introduction
22.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
22.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
22.3.1. By Therapy Type
22.3.2. By Route of Administration
22.3.3. By Patient Type
22.3.4. By Distribution Channel
22.4. Market Attractiveness Analysis
23. Japan Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029
23.1. Introduction
23.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
23.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
23.3.1. By Therapy Type
23.3.2. By Route of Administration
23.3.3. By Patient Type
23.3.4. By Distribution Channel
23.4. Market Attractiveness Analysis
24. South Korea Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029
24.1. Introduction
24.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
24.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
24.3.1. By Therapy Type
24.3.2. By Route of Administration
24.3.3. By Patient Type
24.3.4. By Distribution Channel
24.4. Market Attractiveness Analysis
25. Australia Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029
25.1. Introduction
25.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
25.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
25.3.1. By Therapy Type
25.3.2. By Route of Administration
25.3.3. By Patient Type
25.3.4. By Distribution Channel
25.4. Market Attractiveness Analysis
26. New Zealand Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029
26.1. Introduction
26.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
26.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
26.3.1. By Therapy Type
26.3.2. By Route of Administration
26.3.3. By Patient Type
26.3.4. By Distribution Channel
26.4. Market Attractiveness Analysis
27. Market Structure Analysis
27.1. Market Analysis by Tier of Companies
27.2. Market Concentration
27.3. Market Share Analysis of Top Players
27.4. Market Presence Analysis
27.4.1. By Regional footprint of Players
27.4.2. Product foot print by Players
28. Competition Analysis
28.1. Competition Dashboard
28.2. Competition Benchmarking
28.3. Competition Deep Dive
28.3.1. Teva Pharmaceutical Industries Ltd.
28.3.1.1. Overview
28.3.1.2. Product Portfolio
28.3.1.3. Profitability by Market Segments (Product/Channel/Region)
28.3.1.4. Sales Footprint
28.3.1.5. Strategy Overview
28.3.1.5.1. Marketing Strategy
28.3.1.5.2. Product Strategy
28.3.1.5.3. Channel Strategy
28.3.2. Allergan, Inc.
28.3.2.1. Overview
28.3.2.2. Product Portfolio
28.3.2.3. Profitability by Market Segments (Product/Channel/Region)
28.3.2.4. Sales Footprint
28.3.2.5. Strategy Overview
28.3.2.5.1. Marketing Strategy
28.3.2.5.2. Product Strategy
28.3.2.5.3. Channel Strategy
28.3.3. Ferring Pharmaceuticals
28.3.3.1. Overview
28.3.3.2. Product Portfolio
28.3.3.3. Profitability by Market Segments (Product/Channel/Region)
28.3.3.4. Sales Footprint
28.3.3.5. Strategy Overview
28.3.3.5.1. Marketing Strategy
28.3.3.5.2. Product Strategy
28.3.3.5.3. Channel Strategy
28.3.4. AbbVie Inc.
28.3.4.1. Overview
28.3.4.2. Product Portfolio
28.3.4.3. Profitability by Market Segments (Product/Channel/Region)
28.3.4.4. Sales Footprint
28.3.4.5. Strategy Overview
28.3.4.5.1. Marketing Strategy
28.3.4.5.2. Product Strategy
28.3.4.5.3. Channel Strategy
28.3.5. Aurobindo Pharma Limited
28.3.5.1. Overview
28.3.5.2. Product Portfolio
28.3.5.3. Profitability by Market Segments (Product/Channel/Region)
28.3.5.4. Sales Footprint
28.3.5.5. Strategy Overview
28.3.5.5.1. Marketing Strategy
28.3.5.5.2. Product Strategy
28.3.5.5.3. Channel Strategy
28.3.6. Bayer AG
28.3.6.1. Overview
28.3.6.2. Product Portfolio
28.3.6.3. Profitability by Market Segments (Product/Channel/Region)
28.3.6.4. Sales Footprint
28.3.6.5. Strategy Overview
28.3.6.5.1. Marketing Strategy
28.3.6.5.2. Product Strategy
28.3.6.5.3. Channel Strategy
28.3.7. Mylan N.V.
28.3.7.1. Overview
28.3.7.2. Product Portfolio
28.3.7.3. Profitability by Market Segments (Product/Channel/Region)
28.3.7.4. Sales Footprint
28.3.7.5. Strategy Overview
28.3.7.5.1. Marketing Strategy
28.3.7.5.2. Product Strategy
28.3.7.5.3. Channel Strategy
28.3.8. Pfizer Inc.
28.3.8.1. Overview
28.3.8.2. Product Portfolio
28.3.8.3. Profitability by Market Segments (Product/Channel/Region)
28.3.8.4. Sales Footprint
28.3.8.5. Strategy Overview
28.3.8.5.1. Marketing Strategy
28.3.8.5.2. Product Strategy
28.3.8.5.3. Channel Strategy
28.3.9. Merck & Co., Inc
28.3.9.1. Overview
28.3.9.2. Product Portfolio
28.3.9.3. Profitability by Market Segments (Product/Channel/Region)
28.3.9.4. Sales Footprint
28.3.9.5. Strategy Overview
28.3.9.5.1. Marketing Strategy
28.3.9.5.2. Product Strategy
28.3.9.5.3. Channel Strategy
28.3.10. AMAG Pharmaceuticals
28.3.10.1. Overview
28.3.10.2. Product Portfolio
28.3.10.3. Profitability by Market Segments (Product/Channel/Region)
28.3.10.4. Sales Footprint
28.3.10.5. Strategy Overview
28.3.10.5.1. Marketing Strategy
28.3.10.5.2. Product Strategy
28.3.10.5.3. Channel Strategy
28.3.11. Bausch Health Companies Inc.
28.3.11.1. Overview
28.3.11.2. Product Portfolio
28.3.11.3. Profitability by Market Segments (Product/Channel/Region)
28.3.11.4. Sales Footprint
28.3.11.5. Strategy Overview
28.3.11.5.1. Marketing Strategy
28.3.11.5.2. Product Strategy
28.3.11.5.3. Channel Strategy
28.3.12. Novartis International AG
28.3.12.1. Overview
28.3.12.2. Product Portfolio
28.3.12.3. Profitability by Market Segments (Product/Channel/Region)
28.3.12.4. Sales Footprint
28.3.12.5. Strategy Overview
28.3.12.5.1. Marketing Strategy
28.3.12.5.2. Product Strategy
28.3.12.5.3. Channel Strategy
28.3.13. Sun Pharmaceutical Industries Ltd.
28.3.13.1. Overview
28.3.13.2. Product Portfolio
28.3.13.3. Profitability by Market Segments (Product/Channel/Region)
28.3.13.4. Sales Footprint
28.3.13.5. Strategy Overview
28.3.13.5.1. Marketing Strategy
28.3.13.5.2. Product Strategy
28.3.13.5.3. Channel Strategy
28.3.14. Sanofi S.A.
28.3.14.1. Overview
28.3.14.2. Product Portfolio
28.3.14.3. Profitability by Market Segments (Product/Channel/Region)
28.3.14.4. Sales Footprint
28.3.14.5. Strategy Overview
28.3.14.5.1. Marketing Strategy
28.3.14.5.2. Product Strategy
28.3.14.5.3. Channel Strategy
29. Assumptions and Acronyms Used
30. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Expenditure on Health (% of GDP) by Country, 2016 - 2021
Table 02: Expenditure on Health (% of GDP) by Country, 2016 - 2021
Table 03: Pricing Analysis by Therapy Type, 2021
Table 04: Global Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type
Table 05: Global Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration
Table 06: Global Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type
Table 07: Global Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Table 08: Global Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Region
Table 09: North America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Country
Table 10: North America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type
Table 11: North America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration
Table 12: North America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type
Table 13: North America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Table 14: Latin America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Country
Table 15: Latin America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type
Table 16: Latin America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration
Table 17: Latin America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type
Table 18: Latin America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Table 19: Europe Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Country
Table 20: Europe Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type
Table 21: Europe Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration
Table 22: Europe Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type
Table 23: Europe Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Table 24: South Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Country
Table 25: South Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type
Table 26: South Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration
Table 27: South Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type
Table 28: South Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Table 29: East Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Country
Table 30: East Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type
Table 31: East Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration
Table 32: East Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type
Table 33: East Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Table 34: Oceania Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Country
Table 35: Oceania Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type
Table 36: Oceania Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration
Table 37: Oceania Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type
Table 38: Oceania Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Table 39: MEA Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Country
Table 40: MEA Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type
Table 41: MEA Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration
Table 42: MEA Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type
Table 43: MEA Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Table 44: Emerging countries Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By region
Table 45: China Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type
Table 46: China Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration
Table 47: China Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type
Table 48: China Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Table 49: India Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type
Table 50: India Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration
Table 51: India Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type
Table 52: India Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Table 53: Brazil Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type
Table 54: Brazil Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration
Table 55: Brazil Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type
Table 56: Brazil Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Table 57: U.S. Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type
Table 58: U.S. Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration
Table 59: U.S. Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type
Table 60: U.S. Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Table 61: Canada Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type
Table 62: Canada Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration
Table 63: Canada Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type
Table 64: Canada Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Table 65: Japan Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type
Table 66: Japan Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration
Table 67: Japan Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type
Table 68: Japan Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Table 69: South Korea Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type
Table 70: South Korea Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration
Table 71: South Korea Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type
Table 72: South Korea Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Table 73: Australia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type
Table 74: Australia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration
Table 75: Australia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type
Table 76: Australia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Table 77: New Zealand Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type
Table 78: New Zealand Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration
Table 79: New Zealand Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type
Table 80: New Zealand Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Preterm Birth Prevention and Management Market Share, By Country (2021)
Figure 02: Preterm Birth Prevention and Management Market Share, By Therapy Type (2021)
Figure 03: Preterm Birth Prevention and Management Market Share, By Route of Administration (2021)
Figure 04: Preterm Birth Prevention and Management Market Share, By Patient Type (2021)
Figure 05: Preterm Birth Prevention and Management Market Share, By Distribution Channel (2021)
Figure 06: GDP (US$ Trillion) and Healthcare Expenditure % (2017)
Figure 07: Net National income, Income Growth and Employment (2014)
Figure 08: Global Preterm Birth Prevention and Management Market Value Analysis (US$ Mn), 2014-2021
Figure 09: Global Preterm Birth Prevention and Management Market Value Analysis (US$ Mn), 2022-2029
Figure 10: Global Preterm Birth Prevention and Management Market Absolute $ Opportunity, 2014-2021
Figure 11: Global Preterm Birth Prevention and Management Market Absolute $ Opportunity, 2022-2029
Figure 12: Global Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029
Figure 13: Global Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029
Figure 14: Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By Therapy Type
Figure 15: Global Preterm Birth Prevention and Management Market Share Analysis (%) By Route of Administration, 2022 & 2029
Figure 16: Global Preterm Birth Prevention and Management Market Y-o-Y Growth (%) By Route of Administration, 2022-2029
Figure 17: Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By Route of Administration
Figure 18: Global Preterm Birth Prevention and Management Market Share Analysis (%) By Patient Type , 2022 & 2029
Figure 19: Global Preterm Birth Prevention and Management Market Y-o-Y Growth (%) By Patient Type , 2022-2029
Figure 20: Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By Patient Type
Figure 21: Global Preterm Birth Prevention and Management Market Share Analysis (%) By Distribution Channel , 2022 & 2029
Figure 22: Global Preterm Birth Prevention and Management Market Y-o-Y Growth (%) By Distribution Channel , 2022-2029
Figure 23: Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By Distribution Channel
Figure 24: Global Preterm Birth Prevention and Management Market Share Analysis (%) By Region, 2022 & 2029
Figure 25: Global Preterm Birth Prevention and Management Market Y-o-Y Growth (%) By Region, 2022-2029
Figure 26: Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By Region
Figure 27: North America Preterm Birth Prevention and Management Market Size (US$ Mn), 2014-2021
Figure 28: North America Preterm Birth Prevention and Management Market Size (US$) & Y-o-Y Growth (%), 2022-2029
Figure 29: North America Preterm Birth Prevention and Management Market Analysis by Country - 2022 & 2029
Figure 30: North America Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Country, 2022-2029
Figure 31: North America Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029
Figure 32: North America Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029
Figure 33: North America Preterm Birth Prevention and Management Market Attractiveness Analysis by Country, 2022-2029
Figure 34: North America Preterm Birth Prevention and Management Market Attractiveness Analysis by Therapy Type, 2022-2029
Figure 35: North America Preterm Birth Prevention and Management Market Attractiveness Analysis by Route of Administration, 2022-2029
Figure 36: North America Preterm Birth Prevention and Management Market Attractiveness Analysis by Patient Type, 2022-2029
Figure 37: North America Preterm Birth Prevention and Management Market Attractiveness Analysis by Distribution Channel, 2022-2029
Figure 38: Latin America Preterm Birth Prevention and Management Market Size (US$ Mn), 2014-2021
Figure 39: Latin America Preterm Birth Prevention and Management Market Size (US$) & Y-o-Y Growth (%), 2022-2029
Figure 40: Latin America Preterm Birth Prevention and Management Market Analysis by Country - 2022 & 2029
Figure 41: Latin America Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Country, 2022-2029
Figure 42: Latin America Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029
Figure 43: Latin America Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029
Figure 44: Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis by Country, 2022-2029
Figure 45: Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis by Therapy Type, 2022-2029
Figure 46: Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis by Route of Administration, 2022-2029
Figure 47: Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis by Patient Type, 2022-2029
Figure 48: Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis by Distribution Channel, 2022-2029
Figure 49: Europe Preterm Birth Prevention and Management Market Size (US$ Mn), 2014-2021
Figure 50: Europe Preterm Birth Prevention and Management Market Size (US$) & Y-o-Y Growth (%), 2022-2029
Figure 51: Europe Preterm Birth Prevention and Management Market Analysis by Country - 2022 & 2029
Figure 52: Europe Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Country, 2022-2029
Figure 53: Europe Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029
Figure 54: Europe Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029
Figure 55: Europe Preterm Birth Prevention and Management Market Attractiveness Analysis by Country, 2022-2029
Figure 56: Europe Preterm Birth Prevention and Management Market Attractiveness Analysis by Therapy Type, 2022-2029
Figure 57: Europe Preterm Birth Prevention and Management Market Attractiveness Analysis by Route of Administration, 2022-2029
Figure 58: Europe Preterm Birth Prevention and Management Market Attractiveness Analysis by Patient Type, 2022-2029
Figure 59: Europe Preterm Birth Prevention and Management Market Attractiveness Analysis by Distribution Channel, 2022-2029
Figure 60: South Asia Preterm Birth Prevention and Management Market Size (US$ Mn), 2014-2021
Figure 61: South Asia Preterm Birth Prevention and Management Market Size (US$) & Y-o-Y Growth (%), 2022-2029
Figure 62: South Asia Preterm Birth Prevention and Management Market Analysis by Country - 2022 & 2029
Figure 63: South Asia Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Country, 2022-2029
Figure 64: South Asia Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029
Figure 65: South Asia Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029
Figure 66: South Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Country, 2022-2029
Figure 67: South Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Therapy Type, 2022-2029
Figure 68: South Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Route of Administration, 2022-2029
Figure 69: South Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Patient Type, 2022-2029
Figure 70: South Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Distribution Channel, 2022-2029
Figure 71: East Asia Preterm Birth Prevention and Management Market Size (US$ Mn), 2014-2021
Figure 72: East Asia Preterm Birth Prevention and Management Market Size (US$) & Y-o-Y Growth (%), 2022-2029
Figure 73: East Asia Preterm Birth Prevention and Management Market Analysis by Country - 2022 & 2029
Figure 74: East Asia Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Country, 2022-2029
Figure 75: East Asia Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029
Figure 76: East Asia Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029
Figure 77: East Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Country, 2022-2029
Figure 78: East Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Therapy Type, 2022-2029
Figure 79: East Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Route of Administration, 2022-2029
Figure 80: East Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Patient Type, 2022-2029
Figure 81: East Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Distribution Channel, 2022-2029
Figure 82: Oceania Preterm Birth Prevention and Management Market Size (US$ Mn), 2014-2021
Figure 83: Oceania Preterm Birth Prevention and Management Market Size (US$) & Y-o-Y Growth (%), 2022-2029
Figure 84: Oceania Preterm Birth Prevention and Management Market Analysis by Country - 2022 & 2029
Figure 85: Oceania Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Country, 2022-2029
Figure 86: Oceania Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029
Figure 87: Oceania Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029
Figure 88: Oceania Preterm Birth Prevention and Management Market Attractiveness Analysis by Country, 2022-2029
Figure 89: Oceania Preterm Birth Prevention and Management Market Attractiveness Analysis by Therapy Type, 2022-2029
Figure 90: Oceania Preterm Birth Prevention and Management Market Attractiveness Analysis by Route of Administration, 2022-2029
Figure 91: Oceania Preterm Birth Prevention and Management Market Attractiveness Analysis by Patient Type, 2022-2029
Figure 92: Oceania Preterm Birth Prevention and Management Market Attractiveness Analysis by Distribution Channel, 2022-2029
Figure 93: MEA Preterm Birth Prevention and Management Market Size (US$ Mn), 2014-2021
Figure 94: MEA Preterm Birth Prevention and Management Market Size (US$) & Y-o-Y Growth (%), 2022-2029
Figure 95: MEA Preterm Birth Prevention and Management Market Analysis by Country - 2022 & 2029
Figure 96: MEA Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Country, 2022-2029
Figure 97: MEA Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029
Figure 98: MEA Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029
Figure 99: MEA Preterm Birth Prevention and Management Market Attractiveness Analysis by Country, 2022-2029
Figure 100: MEA Preterm Birth Prevention and Management Market Attractiveness Analysis by Therapy Type, 2022-2029
Figure 101: MEA Preterm Birth Prevention and Management Market Attractiveness Analysis by Route of Administration, 2022-2029
Figure 102: MEA Preterm Birth Prevention and Management Market Attractiveness Analysis by Patient Type, 2022-2029
Figure 103: MEA Preterm Birth Prevention and Management Market Attractiveness Analysis by Distribution Channel, 2022-2029
Figure 104: Emerging countries Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis, 2021
Figure 105: Emerging countries Preterm Birth Prevention and Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2014 - 2029
Figure 106: U.S. Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029
Figure 107: U.S. Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029
Figure 108: Canada Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029
Figure 109: Canada Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029
Figure 110: Japan Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029
Figure 111: Japan Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029
Figure 112: South Korea Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029
Figure 113: South Korea Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029
Figure 114: Australia Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029
Figure 115: Australia Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029
Figure 116: New Zealand Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029
Figure 117: New Zealand Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029
Figure 118: Global Preterm Birth Prevention and Management Market Share, By Value of Prominent Key Players, 2021
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
